These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22507133)

  • 1. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate.
    Kim Y; Fiel MI; Albanis E; Chou HI; Zhang W; Khitrov G; Friedman SL
    Liver Int; 2012 Jul; 32(6):1008-17. PubMed ID: 22507133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats.
    Lin N; Chen S; Pan W; Xu L; Hu K; Xu R
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C469-77. PubMed ID: 21543745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice.
    Kuo WL; Yu MC; Lee JF; Tsai CN; Chen TC; Chen MF
    J Gastrointest Surg; 2012 Feb; 16(2):361-9. PubMed ID: 22068968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.
    Tibaldi E; Zonta F; Bordin L; Magrin E; Gringeri E; Cillo U; Idotta G; Pagano MA; Brunati AM
    Biochim Biophys Acta; 2014 Feb; 1843(2):288-98. PubMed ID: 24140598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
    Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
    J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis.
    Kinnman N; Francoz C; Barbu V; Wendum D; Rey C; Hultcrantz R; Poupon R; Housset C
    Lab Invest; 2003 Feb; 83(2):163-73. PubMed ID: 12594232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury.
    Kinnman N; Goria O; Wendum D; Gendron MC; Rey C; Poupon R; Housset C
    Lab Invest; 2001 Dec; 81(12):1709-16. PubMed ID: 11742041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases.
    Shaker ME; Ghani A; Shiha GE; Ibrahim TM; Mehal WZ
    Biochim Biophys Acta; 2013 Aug; 1833(8):1992-2003. PubMed ID: 23499874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats.
    Paik YH; Yoon YJ; Lee HC; Jung MK; Kang SH; Chung SI; Kim JK; Cho JY; Lee KS; Han KH
    Exp Mol Med; 2011 Jun; 43(6):341-9. PubMed ID: 21499011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
    El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
    J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.
    Shiha GE; Abu-Elsaad NM; Zalata KR; Ibrahim TM
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):788-97. PubMed ID: 25115651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.
    Matei D; Chang DD; Jeng MH
    Clin Cancer Res; 2004 Jan; 10(2):681-90. PubMed ID: 14760091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
    Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
    J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β.
    Ohishi J; Aoki M; Nabeshima K; Suzumiya J; Takeuchi T; Ogose A; Hakozaki M; Yamashita Y; Iwasaki H
    BMC Cancer; 2013 May; 13():224. PubMed ID: 23642185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice.
    Rhee CK; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim YK; Kim KH; Kim TJ; Kim JW
    Respiration; 2011; 82(3):273-87. PubMed ID: 21659722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model.
    Demestre M; Herzberg J; Holtkamp N; Hagel C; Reuss D; Friedrich RE; Kluwe L; Von Deimling A; Mautner VF; Kurtz A
    J Neurooncol; 2010 May; 98(1):11-9. PubMed ID: 19921098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis.
    Kim DC; Jun DW; Kwon YI; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Kim EK
    Liver Int; 2013 Apr; 33(4):535-43. PubMed ID: 23362947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
    He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
    Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
    McGary EC; Onn A; Mills L; Heimberger A; Eton O; Thomas GW; Shtivelband M; Bar-Eli M
    J Invest Dermatol; 2004 Feb; 122(2):400-5. PubMed ID: 15009722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.